Alzheimer's Blockbuster Is Coming, but Slowly




Developers of Alzheimer’s drugs have work cut out for them getting the treatments to patients.




Developers of Alzheimer’s drugs have work cut out for them getting the treatments to patients.

FOLLOW US ON GOOGLE NEWS

Read original article here

Denial of responsibility! Techno Blender is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – admin@technoblender.com. The content will be deleted within 24 hours.
4523.TOAlzheimer's DiseaseAlzheimer039sBIIBBiogenBiotechnology Servicesblockbusterbusiness newsC&E Industry News FiltercomingContent TypescorporateCorporate/Industrial NewsdementiaEconomyEisaiEli LillyFactiva Filtersgeneral newsgovernment policyHealthhealthcareHealthcare/Life SciencesHeard on the Streetindustrial newsJP:4523life sciencesLLYMarketMedical Conditionsmedical treatmentsMedical Treatments/ProceduresMedicationsMental DisordersNeurodegenerative Disease Drugsnew productsNew Products/ServicesPharmaceuticalspoliticalPolitical/General NewsproceduresProductProduct/Service ApprovalsProductsProducts/ServicesregulationRegulation/Government Policyservice approvalsServicesSlowlyspecialized drugsSpecialized Drugs/MedicationsSYNDWSJ-PRO-WSJ.com
Comments (0)
Add Comment